El Salvador vs Honduras: Access to anti-retroviral drugs, male
El Salvador
78.0%
in 2024
Honduras
76.0%
in 2024
El Salvador rank
51st
Honduras rank
54th
Access to anti-retroviral drugs, male over time
- El Salvador
- Honduras
How they compare
El Salvador currently reports 78.0% against 76.0% in Honduras, a difference of 2.0%.
The two have swapped places 5 times across 25 shared years of data; in 2000 it was Honduras ahead.
El Salvador ranks 51st and Honduras ranks 54th of 141 countries.
El Salvador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | El Salvador | Honduras | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.1% | 10.1% | 3.0% | El Salvador |
| 2010s | 50.7% | 45.1% | 5.6% | El Salvador |
| 2020s | 75.4% | 69.6% | 5.8% | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, El Salvador or Honduras?
- El Salvador, at 78.0% against 76.0% in Honduras as of 2024.
- What is the difference in access to anti-retroviral drugs, male between El Salvador and Honduras?
- 2.0%, with El Salvador ahead.
- How many years of comparable data are there for El Salvador and Honduras?
- 25 years are reported by both, from 2000 to 2024.
- How do El Salvador and Honduras rank globally for access to anti-retroviral drugs, male?
- El Salvador ranks 51st and Honduras ranks 54th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.